Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma

This publication has 22 references indexed in Scilit:

• Salvage Second Hematopoietic Cell Transplantation in Myeloma
  Transplantation and Cellular Therapy, 2013
• Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT
  Bone Marrow Transplantation, 2012
• Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry
  Transplantation and Cellular Therapy, 2011
• Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation
  Leukemia & Lymphoma, 2011
• International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
  Blood, 2011
• Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma
  Leukemia & Lymphoma, 2009
• Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
  Bone Marrow Transplantation, 2008
• Improved survival in multiple myeloma and the impact of novel therapies
  Blood, 2008
• Long‐term outcome results of the first tandem autotransplant trial for multiple myeloma
  British Journal of Haematology, 2006
• Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
  New England Journal of Medicine, 2003